|
JKAMP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.92900000031793E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.97316999999142E-05 |
| Normal-vs-Stage2 |
6.574700E-04 |
| Normal-vs-Stage3 |
2.67220000016444E-07 |
| Normal-vs-Stage4 |
1.00339999642429E-08 |
| Stage1-vs-Stage2 |
7.990600E-01 |
| Stage1-vs-Stage3 |
1.171200E-01 |
| Stage1-vs-Stage4 |
5.636200E-03 |
| Stage2-vs-Stage3 |
4.191400E-01 |
| Stage2-vs-Stage4 |
9.407600E-02 |
| Stage3-vs-Stage4 |
2.480000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59189999965537E-07 |
| Normal-vs-AfricanAmerican |
1.983590E-02 |
| Normal-vs-Asian |
5.596200E-04 |
| Caucasian-vs-AfricanAmerican |
3.373800E-01 |
| Caucasian-vs-Asian |
6.207200E-01 |
| AfricanAmerican-vs-Asian |
6.065200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.08129999690732E-08 |
| Normal-vs-Female |
2.59229999999278E-06 |
| Male-vs-Female |
1.823050E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.023270E-04 |
| Normal-vs-Age(41-60Yrs) |
2.23320000003469E-06 |
| Normal-vs-Age(61-80Yrs) |
4.39639999960661E-08 |
| Normal-vs-Age(81-100Yrs) |
3.628400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.707000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.221900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.523200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.295200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.663400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.565200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.707690E-02 |
| Classical-VS-Follicular |
3.038400E-01 |
| Classical-VS-Other |
4.310800E-01 |
| Classical-VS-Normal |
1.71616999999902E-05 |
| Tall-VS-Follicular |
2.625000E-01 |
| Tall-VS-Other |
8.077200E-01 |
| Tall-VS-Normal |
1.90519999998529E-06 |
| Follicular-VS-Other |
7.684200E-01 |
| Follicular-VS-Normal |
1.166900E-04 |
| Other-VS-Normal |
1.611900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70980000002707E-06 |
| Normal-vs-N1 |
4.52280000118321E-08 |
| N0-vs-N1 |
5.531600E-02 |
|
|
